Distant metastasis

1 paper1 finding

Humans1

Associations

1

SGLT2 inhibitors

downin humans1HR 0.676

1 study

SGLT2 inhibitors lower the risk of distant metastasis in humans (HR 0.676, 95% CI 0.532-0.859).
Humansin adult women with breast cancer, mastectomy, and type 2 diabetes5-year follow-upfemales
SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis
EClinicalMedicine28 Jul 2026

More on SGLT2 inhibitors

Latest

2 in 12 months

Healthcare15 Sep

Turkish Cross-Cultural Adaptation of the BRIEF-MPI in Older Adults with Cancer: Convergent and Discriminative Validity Compared with the G8 and Clinical Frailty Scale

Cross-sectional study of 177 peopleClinical Frailty Scale

EClinicalMedicine7 Aug

SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis

Cohort study of 3,569 peopleSGLT2 inhibitors